Rhythm Pharmaceuticals
RYTM
RYTM
227 hedge funds and large institutions have $4.2B invested in Rhythm Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 74 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
227
Holders Change
–
Holders Change %
0%
% of All Funds
3.04%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.13%
New
34
Increased
92
Reduced
74
Closed
33
Calls
$13.8M
Puts
$36.7M
Net Calls
-$22.9M
Net Calls Change
-$40.9M
Top Buyers
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$47.4M |
| 2 |
JPMorgan Chase & Co
New York
|
+$40.4M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$32.5M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$21.5M |
| 5 |
ClearBridge Investments
New York
|
+$19.7M |
Top Sellers
| 1 |
Primecap Management
Pasadena,
California
|
-$57.5M |
| 2 |
BlackRock
New York
|
-$37.1M |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$36M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$33.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$19.1M |
